News

Sotyktu significantly outperformed placebo for the treatment of psoriatic arthritis in a phase 3 trial, meeting key endpoints ...
Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.
In this video, Peter Lio, MD, highlighted research from the American Academy of Dermatology meeting and said his biggest takeaway from the meeting was that dermatologists are in “the decade of atopic ...
Aimed at addressing systemic inflammation, National Rosacea Society treatment algorithms take a phenotype-driven approach ...
Deeptej Singh, MD, a board-certified dermatologist, discusses why it's common for people living with HS to try several ...
Deeptej Singh, MD, a board-certified dermatologist, discusses how to get a diagnosis of atopic dermatitis (eczema).
Posters presented at the 2025 American Academy of Dermatology Annual Meeting found tildrakizumab outcomes to have a mean drug ...
Hidradenitis suppurativa (HS) highlights from AAD 2025 include studies of HS patients' risk for cardiovascular disease or ...
The following is a summary of “Autologous Cell Harvesting Device Provides Repigmentation and Improves Quality-of-Life for ...
Almirall has announced that it will be hosting the 16th edition of its Skin Academy, a conference that encourages collaboration and the development of new methods and solutions in the field of ...